Metropolis Healthcare share news, announcements and annual reports
NSE: METROPOLISBSE: 542650Healthcare ServicesSmall Cap
Metropolis Healthcare Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2019 · Issue price ₹880
Last close ₹551.20up ₹0.70 (0.13%)BSE ₹551.65
Share price at the NSE close on 28 Oct 2026. Previous close ₹550.50.
28 Oct: open ₹552.00, high ₹563.40, low ₹545.20
52-week range of traded prices to 28 Oct 2026
₹412.25Low, 2 Apr 2026₹609.05High, 30 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹11,435 Cr557th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 56.71
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.36%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,06,97646.9% delivered
Metropolis Healthcare analyst meets
148 filed, newest first. Page 1 of 3.
Oct 2026
Aug 2026
20 Aug · Analysts
Jul 2026
Jun 2026
4 Jun · Analysts
May 2026
27 May · Analysts
8 May · Analysts
Apr 2026
13 Apr · Analysts
Mar 2026
20 Mar · Analysts
12 Mar · Analysts
2 Mar · Analysts
Feb 2026
Jan 2026
Nov 2025
24 Nov · Analysts
12 Nov · Analysts
Oct 2025
Sep 2025
10 Sep · Analysts
10 Sep · Analysts
Aug 2025
7 Aug · Analysts
Jul 2025
4 Jul · Analysts
Jun 2025
13 Jun · Analysts
May 2025
30 May · Analysts
30 May · Analysts
27 May · Analysts
19 May · Analysts
Mar 2025
4 Mar · Analysts
Feb 2025
24 Feb · Analysts
5 Feb · Analysts
4 Feb · Analysts
Jan 2025
Dec 2024
5 Dec · Analysts
Nov 2024
7 Nov · Analysts
6 Nov · Analysts
Oct 2024
Sep 2024
16 Sep · Analysts
13 Sep · Analysts
3 Sep · Analysts
3 Sep · Analysts
Aug 2024
7 Aug · Analysts